A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

BACKGROUND: As schizophrenia patients are typically suspicious of, or are hostile to changes they may be reluctant to accept generic substitution, possibly affecting compliance. This may counteract drug costs savings due to less symptom control and increased hospitalization risk. Although compliance...

Descripción completa

Detalles Bibliográficos
Autores principales: Treur, Maarten, Heeg, Bart, Möller, Hans-Jürgen, Schmeding, Annette, van Hout, Ben
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652458/
https://www.ncbi.nlm.nih.gov/pubmed/19226465
http://dx.doi.org/10.1186/1472-6963-9-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652458/
https://www.ncbi.nlm.nih.gov/pubmed/19226465
http://dx.doi.org/10.1186/1472-6963-9-32

Ejemplares similares